Riskpilot← Back to searchSign inGet full accessUTx AB
ABActiveOrg 5569846099Carlandersparken 1 Carlanderska SjukhusetMedical specialists activities · NACE 8622Est. 20143 employees
Revenue 2024
SEK 11M
+16% vs 2023
EBITDA margin
40.1%
+9% vs 2023
Equity ratio
2.7%
Financial strength
Net profit 2024
SEK 0
3 employees
| Revenue | SEK 11M | +16% |
| EBITDA | SEK 4,4M | +9% |
| Net profit | SEK 0 | — |
| Total assets | SEK 4,4M | -2% |
| Equity | SEK 121K | +0% |
| Employees | 3 | — |
Legal name
UTx AB
Org number
5569846099
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
29 september 2014
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är hälso-, frisk- och sjukvårdsverksamhet samt forskning. Driva vaccinationsverksamhet samt företagshälsovård samt även bedriva personaluthyrning och därmed förenlig verksamhet.
Address
Carlandersparken 1 Carlanderska Sjukhuset
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 806 | 5 444 | 5 797 | 9 542 | 11 036 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 816 | 1 046 | 657 | 4 070 | 4 424 |
| Depreciation & amort. | −125 | −375 | −584 | −584 | −524 |
| EBIT | 691 | 671 | 73 | 3 486 | 3 900 |
| Net financials | — | — | — | — | 51 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 807 | 3 054 | 4 762 | 4 535 | 4 432 |
| Equity | 121 | 121 | 121 | 121 | 121 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 536 | 2 383 | 4 132 | 4 414 | 4 311 |
| Total debt | 2 536 | 2 383 | 4 132 | 4 414 | 4 311 |
EBITDA margin
40.1%
This company
15.8%
Market median
+154% vs market
20202024
Equity ratio
2.7%
This company
38.2%
Market median
-93% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
2.49×
This company
1.12×
Market median
+122% vs market
20202024
Debt / equity
35.63×
This company
0.62×
Market median
-5647% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DF Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
LE Chief Auditor | Chief Auditor | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UTx AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda Elisabeth Sallander | Chief Auditor | 0 companies |
| David Fredrik Lawenius | Chief Auditor | 0 companies |
| Saskia Maria Catharina Eklind | Chairman | 0 companies |
| Malin Ulrika Ulfsdotter Bäcker | Deputy Board Member | 0 companies |
| Anna Katarina Brywe | Board of Directors | 0 companies |
| Linn Ekhed | Deputy Board Member | 0 companies |
| Bernth Mathias Pålsson | Deputy Board Member | 0 companies |